Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.010
EU - Europa 3.793
AS - Asia 1.765
SA - Sud America 104
AF - Africa 15
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.835
CN - Cina 717
DE - Germania 680
RU - Federazione Russa 606
SE - Svezia 580
SG - Singapore 579
UA - Ucraina 513
IE - Irlanda 469
IT - Italia 366
HK - Hong Kong 265
CA - Canada 170
GB - Regno Unito 164
FI - Finlandia 122
AT - Austria 108
BR - Brasile 93
FR - Francia 76
VN - Vietnam 70
IN - India 43
NL - Olanda 30
CZ - Repubblica Ceca 24
ID - Indonesia 24
TR - Turchia 18
DK - Danimarca 17
BE - Belgio 13
JP - Giappone 10
NZ - Nuova Zelanda 7
AU - Australia 6
BG - Bulgaria 5
IQ - Iraq 5
IR - Iran 5
EG - Egitto 4
ES - Italia 4
LB - Libano 4
TH - Thailandia 4
BD - Bangladesh 3
CH - Svizzera 3
CO - Colombia 3
MX - Messico 3
PE - Perù 3
PT - Portogallo 3
VE - Venezuela 3
AZ - Azerbaigian 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
MD - Moldavia 2
PA - Panama 2
PL - Polonia 2
SC - Seychelles 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CM - Camerun 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TJ - Tagikistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 14.703
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Fairfield 865
Houston 766
Jacksonville 565
Dublin 458
Chandler 456
Ashburn 428
Singapore 373
Wilmington 363
Seattle 351
Dearborn 346
Cambridge 302
Hong Kong 262
Frankfurt am Main 244
Princeton 225
New York 191
Nanjing 119
Altamura 108
Hangzhou 107
Milan 104
Santa Clara 103
Beijing 101
Lachine 97
Lawrence 95
Vienna 95
Shanghai 90
Nanchang 46
Moscow 43
San Diego 39
Shenyang 32
Ottawa 31
Dong Ket 30
Hebei 29
Jiaxing 26
Brno 23
Andover 22
Norwalk 22
Toronto 22
Council Bluffs 21
Tianjin 21
Falls Church 20
Helsinki 20
Jakarta 20
Guangzhou 19
Jinan 19
Munich 17
Ningbo 17
Mountain View 16
London 15
Changsha 14
Fremont 14
Huizen 14
Boardman 13
Brussels 11
Hefei 10
Kunming 10
Chicago 9
Zhengzhou 9
Beauharnois 8
Lissone 8
Düsseldorf 7
Kilburn 7
Nuremberg 7
Los Angeles 6
San Mateo 6
São Paulo 6
Edmonton 5
Lappeenranta 5
Montréal 5
Newark 5
Phoenix 5
Redmond 5
Rome 5
Sacramento 5
Taizhou 5
Turin 5
Auckland 4
Bangkok 4
Lauterbourg 4
Nürnberg 4
San Francisco 4
Sofia 4
University Park 4
Ankara 3
Auburn Hills 3
Bari 3
Brasília 3
Campodarsego 3
Cincinnati 3
Congonhas 3
Dallas 3
Groningen 3
Hanoi 3
Jaipur 3
Kiev 3
Laurel 3
Leawood 3
Linköping 3
Messina 3
Totale 10.611
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 306
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 248
Dyspnea in crackling lungs 226
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 219
Impact of traffic-related air pollution on pulmonary oxidative stress 215
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 204
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 201
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 197
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 197
Clinical phenotypes in adult patients with bronchiectasis 195
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 192
A 61-year-old female with chronic cough and purulent sputum 183
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 183
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 178
A 13-year-old female with shortness of breath and pleuritic chest pain 177
Mixed community-acquired lower respiratory tract infections 176
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 175
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 169
Hospital admission decision for patients with community-acquired pneumonia 169
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 166
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 160
The management of community-acquired pneumonia in the elderly 160
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 159
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 157
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 156
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 155
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 155
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 154
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 152
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 149
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 148
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 148
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 146
Strategic targets of essential host-pathogen interactions 145
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 145
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 145
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 144
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 144
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 143
Pneumonia: how important are local epidemiology and smoking habits? 142
100 years of respiratory medicine: pneumonia 141
Compliance with anti-H1N1 vaccine among healthcare workers and general population 141
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 138
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 136
The bronchiectasis severity index. An international derivation and validation study 136
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 136
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 135
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 135
Impact of exacerbations in the natural course of COPD 135
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 134
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 133
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 133
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 131
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 131
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 131
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 131
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 130
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 129
Azithromycin and lower respiratory tract infections 128
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 128
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 128
The role of biomarkers in low respiratory tract infections 128
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 127
Individualizing duration of antibiotic therapy in community-acquired pneumonia 127
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 126
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 125
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 124
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 124
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 124
Antibiotics as immunomodulant agents in COPD 123
Pneumococcal Vaccine and Patients with Pulmonary Diseases 121
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 119
Acute exacerbation of COPD: application of evidence-based guidelines 119
Chlamydophila pneumoniae 119
Management of nontuberculous mycobacterial infection in the elderly 119
Where are the acutely ill best cared for and who should look after them? 118
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 118
The management of patients with community-acquired pneumonia beyond antibiotic therapy 115
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 113
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 112
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 112
Cardiac diseases complicating community-acquired pneumonia 112
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 111
Telithromycin in lower respiratory tract infections 109
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 107
Chlamydia pneumoniae and Mycoplasma pneumoniae 107
Clinical applications of azithromycin microspheres in respiratory tract infections 107
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 106
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 105
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 102
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 102
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 101
Healthcare-associated pneumonia: where do we go next? 97
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 97
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 96
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 95
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 94
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 93
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 92
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study 89
Totale 14.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020361 0 0 0 0 0 0 0 0 0 118 175 68
2020/20211.586 134 84 165 168 108 82 145 139 146 219 69 127
2021/20221.059 51 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/20251.908 205 348 76 141 275 60 82 79 313 329 0 0
Totale 14.930